167 related articles for article (PubMed ID: 28045618)
41. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
Figueras J; Jaurrieta E; Valls C; Benasco C; Rafecas A; Xiol X; Fabregat J; Casanovas T; Torras J; Baliellas C; Ibañez L; Moreno P; Casais L
Hepatology; 1997 Jun; 25(6):1485-9. PubMed ID: 9185772
[TBL] [Abstract][Full Text] [Related]
42. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis.
Qin LX; Tang ZY
World J Gastroenterol; 2003 Mar; 9(3):385-91. PubMed ID: 12632482
[TBL] [Abstract][Full Text] [Related]
43. Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Liu J; Ni W; Qu L; Cui X; Lin Z; Liu Q; Zhou H; Ni R
Dig Dis Sci; 2016 Sep; 61(9):2554-67. PubMed ID: 27221498
[TBL] [Abstract][Full Text] [Related]
44. [Effective ways to improve the prognosis of advanced stage (BCLC stage C) hepatocellular carcinoma].
Cheng S; Wei X; Wu M
Zhonghua Wai Ke Za Zhi; 2015 May; 53(5):324-7. PubMed ID: 26082244
[TBL] [Abstract][Full Text] [Related]
45. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
46. [Long survival after resection of cranial metastases from hepatocellular carcinoma. Case report and review of the literature].
Sánchez-Delgado J; Calzado S; de Haro C; Mas M; Miquel M; Casas M; Vergara M; Dalmau B; Gil M
Gastroenterol Hepatol; 2012 Jan; 35(1):12-6. PubMed ID: 22177938
[TBL] [Abstract][Full Text] [Related]
47. Extrahepatic metastases of hepatocellular carcinoma.
Katyal S; Oliver JH; Peterson MS; Ferris JV; Carr BS; Baron RL
Radiology; 2000 Sep; 216(3):698-703. PubMed ID: 10966697
[TBL] [Abstract][Full Text] [Related]
48. Brain metastasis from hepatocellular carcinoma after radical hepatectomy.
Asahara T; Yano M; Fukuda S; Fukuda T; Nakahara H; Katayama K; Itamoto T; Dohi K; Nakanishi T; Kitamoto M; Azuma K; Ito K; Moriwaki K; Yuge O; Shimamoto F
Hiroshima J Med Sci; 1999 Sep; 48(3):91-4. PubMed ID: 10598411
[TBL] [Abstract][Full Text] [Related]
49. Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma.
Kawaoka T; Aikata H; Hyogo H; Morio R; Morio K; Hatooka M; Fukuhara T; Kobayashi T; Naeshiro N; Miyaki D; Hiramatsu A; Imamura M; Kawakami Y; Takahashi S; Waki K; Tsuji K; Kohno H; Kohno H; Moriya T; Chayama K
J Dig Dis; 2015 Sep; 16(9):505-12. PubMed ID: 26121102
[TBL] [Abstract][Full Text] [Related]
50. Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.
Gandhi M; Choo SP; Thng CH; Tan SB; Low AS; Cheow PC; Goh AS; Tay KH; Lo RH; Goh BK; Wong JS; Ng DC; Soo KC; Liew WM; Chow PK;
BMC Cancer; 2016 Nov; 16(1):856. PubMed ID: 27821083
[TBL] [Abstract][Full Text] [Related]
51. The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy.
Kudo M
J Gastroenterol Hepatol; 2010 Mar; 25(3):439-52. PubMed ID: 20370723
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
[TBL] [Abstract][Full Text] [Related]
53. Pharmacological treatment of hepatocellular carcinoma with cavoatrial tumor thrombus - case series and literature review.
Zhan T; Sollors J; Steinebrunner N; Schlitt HJ; Stroszczynski C; Weiss KH; Ebert MP; Teufel A
Z Gastroenterol; 2019 Apr; 57(4):501-507. PubMed ID: 30965380
[TBL] [Abstract][Full Text] [Related]
54. Prognostic factors of spontaneously ruptured hepatocellular carcinoma.
Han XJ; Su HY; Shao HB; Xu K
World J Gastroenterol; 2015 Jun; 21(24):7488-94. PubMed ID: 26139994
[TBL] [Abstract][Full Text] [Related]
55. Loco-regional intervention for hepatocellular carcinoma.
Lau WY; Lai ECH
J Interv Med; 2019 May; 2(2):43-46. PubMed ID: 34805870
[TBL] [Abstract][Full Text] [Related]
56. Surgical resection for pulmonary metastasis from hepatocellular carcinoma: analysis of prognosis in relation to primary control.
Lee CY; Bae MK; Park IK; Kim DJ; Lee JG; Choi JS; Han KH; Chung KY
J Surg Oncol; 2010 Mar; 101(3):239-43. PubMed ID: 20127898
[TBL] [Abstract][Full Text] [Related]
57. Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence.
Lei J; Zhong J; Hao J; Liu Z; Zhang P; Wu L; Yan L; Zhu J; Zeng Y; Li B; Wen T; Wang W
Oncotarget; 2016 Jul; 7(27):42598-42607. PubMed ID: 26981887
[TBL] [Abstract][Full Text] [Related]
58. Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.
Bettinger D; Spode R; Glaser N; Buettner N; Boettler T; Neumann-Haefelin C; Brunner TB; Gkika E; Maruschke L; Thimme R; Schultheiss M
BMC Gastroenterol; 2017 Aug; 17(1):98. PubMed ID: 28797231
[TBL] [Abstract][Full Text] [Related]
59. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
[TBL] [Abstract][Full Text] [Related]
60. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
